Hammed Ali, Al-Qiami Almonzer, Alzawahreh Ahmad, Rosenbauer Josef, Nada Eman Ayman, Otmani Zina, Hamam Nada G, Alnajjar Asmaa Zakria, Mohamed Hammad Elsayed, Hamamreh Rawan, Kostev Karel, Richter Gregor, Tanislav Christian
Department of Neurology and Geriatrics, Diakonie Hospital Jung Stilling Siegen, Siegen, Germany.
Faculty of Medicine and Health Sciences, Kassala University, Kassala, Sudan.
Cerebrovasc Dis. 2025;54(4):603-616. doi: 10.1159/000541033. Epub 2024 Aug 24.
The treatment of acute ischemic stroke due to large artery vessel occlusion experienced a dramatic development within the last decade. This meta-analysis investigates the effectiveness of bridging therapy (BT) versus mechanical thrombectomy (MT) alone in treating acute ischemic stroke.
Two independent reviewers assessed two-arm clinical trials from Scopus, PubMed, Web of Science, and the Cochrane Library up to January 2024. Data extraction and quality were evaluated using the ROBINS-2 tool. Our primary outcomes were improvement in NIHSS scores and 90-day modified Rankin Scale (mRS) score.
This meta-analysis, which included 2,638 participants from 8 randomized controlled trials, found that BT resulted in a greater improvement in NIHSS scores from baseline compared to endovascular treatment alone (mean difference [MD] 0.96, 95% confidence interval [CI]: [0.73-1.20], p < 0.00001). Additionally, BT group achieved successful recanalization more frequently before and after thrombectomy. Thrombectomy alone hat a shorter time from stroke onset to groin puncture compared to BT (MD 9.91, 95% CI: [4.31-15.52], p = 0.005). Functional outcomes, mortality rates, symptomatic intracerebral hemorrhage rates, and long-term recovery metrics, such as Barthel index and modified Rankin Scale scores, were comparable between both treatment approaches.
BT is superior to endovascular treatment alone based on NIHSS score improvement and successful reperfusion rates before and after thrombectomy. Despite MT alone demonstrating a shorter time from stroke onset to groin puncture (MD of 9.91 min), it did not contribute to greater NIHSS improvement at 24 h and 7 days. Further trials with larger sample sizes are warranted to enhance precision in clinical guidance.
在过去十年中,大动脉血管闭塞所致急性缺血性卒中的治疗取得了显著进展。本荟萃分析旨在研究桥接治疗(BT)与单纯机械取栓术(MT)治疗急性缺血性卒中的有效性。
两名独立评审员评估了截至2024年1月来自Scopus、PubMed、科学网和考克兰图书馆的双臂临床试验。使用ROBINS - 2工具评估数据提取和质量。我们的主要结局指标是美国国立卫生研究院卒中量表(NIHSS)评分的改善以及90天改良Rankin量表(mRS)评分。
本荟萃分析纳入了来自8项随机对照试验的2638名参与者,发现与单纯血管内治疗相比,BT导致NIHSS评分从基线起有更大改善(平均差值[MD] 0.96,95%置信区间[CI]:[0.73 - 1.20],p < 0.00001)。此外,BT组在取栓前后更频繁地实现成功再通。与BT相比,单纯取栓术从卒中发作到腹股沟穿刺的时间更短(MD 9.91,95% CI:[4.31 - 15.52],p = 0.005)。两种治疗方法在功能结局、死亡率、症状性脑出血率以及长期恢复指标(如Barthel指数和改良Rankin量表评分)方面具有可比性。
基于NIHSS评分改善以及取栓前后的成功再灌注率,BT优于单纯血管内治疗。尽管单纯MT从卒中发作到腹股沟穿刺的时间更短(MD为9.91分钟),但在24小时和7天时并未带来更大的NIHSS改善。有必要进行更大样本量的进一步试验,以提高临床指导的准确性。